CurrentKaiser PermanentePolicy N/A

Iontophoresis and Phonophoresis Coverage Criteria

Clinical review criteria governing medical necessity and coverage determinations for iontophoresis (including medication delivery and home devices) and the noncoverage stance for phonophoresis for members of Kaiser Foundation Health Plan of Washington.

Policy Summary

PayerKaiser Permanente

PolicyIontophoresis and Phonophoresis Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionSubmit the last 6 months of clinical notes from the requesting provider and/or specialist to support medical necessity.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

97033CPT code listed for iontophoresis (per 15 minutes)

Not CoveredPhonophoresis coverage stance

MCGGuideline referenced

Home devicesHome devices discussed

Coverage and Medical Necessity Criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Medically necessary condition: Considered medically necessary when criteria in the applicable policy statements (including the MCG iontophoresis guideline KP-0617 for non‑Medicare members) are met.

MCG guidelines are proprietary; Kaiser may reference KP-0617 for non‑Medicare determinations and can share specific criteria for individual utilization reviews.

Phonophoresis Not Medically Necessary

Phonophoresis:

Coverage stance: Phonophoresis is considered not medically necessary per the MCG Phonophoresis guideline (A-0616) and Kaiser Permanente policy.

Designated not medically necessary; no specific CPT/HCPCS codes are listed for coverage.

The policy review found that the use of iontophoresis for hyperhidrosis, various joint and tendon pain syndromes, and temporomandibular joint (TMJ) dysfunction was not supported by sufficient comparative evidence to meet Kaiser Permanente Medical Technology Assessment criteria. MTAC reviews identified primarily small case series and a limited number of randomized trials without consistent demonstration of benefit versus established alternatives, and no published comparative studies for hyperhidrosis. As a result, specific applications of iontophoresis for these indications were determined not to meet the Medical Technology Assessment criteria.

Provider Requirements, Authorization, and Documentation

Prior Authorization

Prior Authorization and Code Guidance

Prior authorization may be required for iontophoresis (97033) and verification is recommended for phonophoresis billing status. Check the plan-specific Pre-authorization Code Check to confirm authorization requirements and correct code use before service.

Affected code: CPT 97033 — iontophoresis, each 15 minutes
Phonophoresis: identified as Not Medically Necessary in policy development; verify coverage prior to billing
Use Pre-authorization Code Check to confirm deleted or plan-restricted codes

Note

Comparative Therapy Context

Comparative therapy context: Iontophoresis has limited and inconsistent evidence versus placebo and has not been adequately compared to established alternatives (corticosteroid injections, oral NSAIDs). Consider evidence-based alternatives when clinically appropriate and document rationale if iontophoresis is selected instead.

Alternatives to consider: corticosteroid injection, oral NSAIDs, other standard conservative therapies
Policy development found insufficient evidence of superiority of iontophoresis over accepted alternatives

Documentation Required

Required Clinical Documentation and Documentation Triggers

Required documentation and denial-risk triggers: Submit recent clinical documentation to support medical necessity. Incomplete or missing documentation listed below increases risk of denial.

Minimum documentation to submit: last 6 months of clinical notes from requesting provider and/or specialist that describe diagnosis, prior treatments, response to prior conservative therapies, and planned course of iontophoresis
Document why alternatives (e.g., injections, NSAIDs) are not appropriate when choosing iontophoresis
Denial-risk triggers: absence of prior conservative therapy documentation, missing treatment rationale, lack of objective findings or pertinent history in the last 6 months
Ensure billing matches service rendered (e.g., CPT 97033 for iontophoresis; do not bill phonophoresis when it is non-covered without prior authorization)

Key Terms and Device Definitions

Iontophoresis — definition and typical therapeutic agents

DefinitionIontophoresis is the use of electricity (low‑intensity direct current) to enhance percutaneous absorption of ionizable drugs by passing DC current between two electrodes; patients typically have little or no sensation during the procedure.

Typical therapeutic agentsDrugs that ionize such as lidocaine hydrochloride (positive ion) and dexamethasone sodium phosphate (negative ion).

Mechanism/advantagesIons in solution are transferred through the skin by DC current; potential advantages include greater convenience and less discomfort than injection, less variation in absorption, and fewer systemic side effects versus oral administration.

Typical current intensityUses a low current; patients usually report minimal or no sensation.

Clinical applications noted in assessmentProposed uses include hyperhidrosis, various tendonitis/joint pain syndromes, and temporomandibular joint (TMJ) dysfunction.

Tap water iontophoresis (home devices) — Drionic, Idrostar and use for hyperhidrosis

Definition (tap water/home devices)Tap water iontophoresis uses battery‑operated devices that apply low‑intensity current (device‑supplied) to the palms and/or soles immersed in an electrolyte or tap‑water solution to treat hyperhidrosis.

Example devicesDevices assessed in the MTAC review include Drionic and Idrostar (battery‑operated home iontophoresis systems).

Typical parametersDescribed application of low intensity current (reported ~15–18 mA in MTAC summary) to palms and/or soles immersed in electrolyte solution.

Target conditionPrimarily used for treatment of primary (essential) or localized hyperhidrosis (commonly palmar, plantar, axillary, or facial).

Place in therapyOne of multiple management options alongside antiperspirants, topical/systemic drugs, botulinum toxin, psychotherapy, and surgery — considered a localized delivery method using electrical current.

Background and Technology Overview

Iontophoresis delivers a low‑intensity direct current through the skin to enhance percutaneous absorption of ionized drug molecules. An electrode containing the charged medication is placed over the target area and a counter electrode completes the circuit so that like charges are repelled and driven into the tissues. Typical drugs evaluated for iontophoretic delivery include local anesthetics (for example, lidocaine) and corticosteroids (for example, dexamethasone), and the procedure is usually performed with currents that produce minimal sensation.